Persistence Market Research is released upcoming report on title "Lung Cancer Therapeutics Market: Global Industry Analysis and Forecast to 2020".
New York, NY -- (SBWIRE) -- 03/26/2015 -- Cancer is a disease of genes which are caused due to abnormal growth of cells. These abnormal cells further migrate from the original site to other site through blood and lymph system. Lung cancer is one of the types of cancer formed in tissues of the lungs. Lung cancer is a malignant lung carcinoma characterized by abnormal cell growth in lung tissue. Lung cancer decreases the lung ability to provide oxygen to bloodstream. Some of the major symptoms of lung cancer include body mucus, coughing, shortness of breath, wheezing, appetite loss, weight loss and chest pain. Cigarette smoking is the prominent cause of lung cancer. Pipe and cigar smoking are some other causes of lung cancer. Lung cancer is treated through surgery, chemotherapy, radiation therapy, immunotherapy and vaccine therapy. The primary lung carcinomas originate from epithelial cells. Non-small cell lung cancer, small cell lung cancer and lung carcinoid tumor are three different types of lung cancer. Non-small cell lung cancer is the most common type of lung cancer and it grows slowly compared to other type of lung cancer. Squamous cell carcinoma, adenocarcinoma and large cell carcinoma are subtypes of non-small cell lung cancer. Small cell lung cancer is also known as oat cell cancer and comprises small cell carcinoma and combined small cell carcinoma. Lung carcinoid tumors are uncommon type of tumor which begins in lungs and are made up of neuroendocrine cells. Some of the drugs used to treat non-small cell lung cancer include avastin, gemzar, taxotere and tarceva.
Buy Full Report: http://www.persistencemarketresearch.com/market-research/lung-cancer-therapeutics-market.asp
North America followed by Europe dominates the global lung cancer therapeutics market due to rising incidence of lung cancer and growing aging population. Asia is expected to show high growth rate due to rising awareness for better healthcare. Emerging countries such as India is expected to be the fastest growing market due to increase in lung cancer population.
In recent time there is increased use of lung cancer therapeutic due to rising tobacco smoking across the world. Rising aging population, lifestyle factors and increasing awareness for health are some of the key driving factors for the growth of the global lung cancer therapeutics market. In addition, innovative and targeted drug delivery to the lung is also fuelling the growth of the global lung cancer therapeutics market. However, availability of large numbers of generic form of drugs and limited treatment options are some of the major factors restraining the growth of the global lung cancer therapeutics market. In addition, increased demand for diagnosis is also restraining the growth of the global lung cancer therapeutics market.
Development of personalized drugs would support the growth of the global lung cancer therapeutics market. Innovative and safer therapies could develop an opportunity for growth of the global lung cancer therapeutics market. However, harmful side effect caused by chemotherapy and radiation therapy could lead a challenge for the global lung cancer therapeutics market. Some of the major companies operating in the global lung cancer therapeutics market are Roche, Eli Lilly and company, Pfizer, Agennix AG and Snaofi-Aventis. Other companies include Daiichi Sankyo, AstraZeneca PLC and GlaxoSmithKline PLC.
Request Full Toc: http://www.persistencemarketresearch.com/toc/3840
Key points covered in the report:
1) Report segments the market on the basis of types, application, products, technology, etc (as applicable)
2) The report covers geographic segmentation
3) The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
4) The report provides company profiles of some of the leading companies operating in the market
The report also provides porters five forces analysis of the market.
Visit our blog at http://pmrblog.com/
About Persistence Market Research
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.
PMR stands committed to bringing more accuracy and speed to clients' business decisions. From ready-to-purchase market research reports to customized research solutions, PMR's engagement models are highly flexible without compromising on its deep-seated research values.